Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #51 to #550.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Fibroblastic/myofibroblastic tumours‏‎ (143 revisions)
  2. Lymphoma‏‎ (140 revisions)
  3. Liver pathology‏‎ (138 revisions)
  4. Malignant melanoma‏‎ (135 revisions)
  5. Colorectal tumours‏‎ (135 revisions)
  6. Peripheral nerve sheath tumours‏‎ (133 revisions)
  7. Vulva‏‎ (132 revisions)
  8. Gallbladder‏‎ (130 revisions)
  9. Heart valves‏‎ (127 revisions)
  10. Gestational trophoblastic disease‏‎ (125 revisions)
  11. Germ cell tumours‏‎ (119 revisions)
  12. Heart‏‎ (116 revisions)
  13. Vermiform appendix‏‎ (113 revisions)
  14. Bone‏‎ (112 revisions)
  15. Dermal cysts‏‎ (112 revisions)
  16. Endometrial carcinoma‏‎ (108 revisions)
  17. Vasculitides‏‎ (108 revisions)
  18. Microorganisms‏‎ (108 revisions)
  19. Small intestine‏‎ (103 revisions)
  20. Meningioma‏‎ (102 revisions)
  21. Adipocytic tumours‏‎ (102 revisions)
  22. Small cell lymphomas‏‎ (101 revisions)
  23. Cases‏‎ (100 revisions)
  24. Pathology links‏‎ (100 revisions)
  25. Vascular disease‏‎ (97 revisions)
  26. Amyloid‏‎ (95 revisions)
  27. Adenocarcinoma of the lung‏‎ (93 revisions)
  28. Pituitary gland‏‎ (91 revisions)
  29. Diffuse lung diseases‏‎ (91 revisions)
  30. Vascular tumours‏‎ (90 revisions)
  31. Pulmonary cytopathology‏‎ (89 revisions)
  32. An introduction to gynecologic pathology‏‎ (89 revisions)
  33. Short power list‏‎ (88 revisions)
  34. Non-invasive breast carcinoma‏‎ (87 revisions)
  35. Fungi‏‎ (86 revisions)
  36. Urothelial carcinoma‏‎ (85 revisions)
  37. Celiac sprue‏‎ (83 revisions)
  38. Neurohistology‏‎ (82 revisions)
  39. Parathyroid glands‏‎ (82 revisions)
  40. Spleen‏‎ (79 revisions)
  41. Cytopathology‏‎ (79 revisions)
  42. Pulmonary pathology‏‎ (78 revisions)
  43. Surgical margins‏‎ (75 revisions)
  44. Thyroid cytopathology‏‎ (74 revisions)
  45. Quality‏‎ (71 revisions)
  46. Pediatric gastrointestinal pathology‏‎ (70 revisions)
  47. Colorectal adenocarcinoma‏‎ (70 revisions)
  48. MEDITECH‏‎ (70 revisions)
  49. Viruses‏‎ (70 revisions)
  50. Mesothelial cytopathology‏‎ (70 revisions)
  51. Libre Pathology‏‎ (69 revisions)
  52. Products of conception‏‎ (68 revisions)
  53. Bacteria‏‎ (67 revisions)
  54. Haematopathology‏‎ (67 revisions)
  55. Papillary renal cell carcinoma‏‎ (67 revisions)
  56. Uterine tubes‏‎ (66 revisions)
  57. Endometrial hyperplasia‏‎ (66 revisions)
  58. Asphyxial deaths‏‎ (66 revisions)
  59. Gross pathology‏‎ (65 revisions)
  60. Penis‏‎ (65 revisions)
  61. Traditional adenoma‏‎ (65 revisions)
  62. Spot diagnoses‏‎ (65 revisions)
  63. Thymus‏‎ (62 revisions)
  64. Gastrointestinal stromal tumour‏‎ (62 revisions)
  65. Anus‏‎ (62 revisions)
  66. Uterus‏‎ (62 revisions)
  67. Oral pathology‏‎ (62 revisions)
  68. Molecular pathology‏‎ (62 revisions)
  69. Bullous diseases‏‎ (61 revisions)
  70. Squamous cell carcinoma‏‎ (61 revisions)
  71. Clear cell renal cell carcinoma‏‎ (61 revisions)
  72. Hodgkin lymphoma‏‎ (60 revisions)
  73. Extramammary Paget disease‏‎ (60 revisions)
  74. Femoral head‏‎ (60 revisions)
  75. Small round cell tumours‏‎ (59 revisions)
  76. Rheumatoid arthritis‏‎ (59 revisions)
  77. Chondrosarcoma‏‎ (59 revisions)
  78. Odontogenic tumours and cysts‏‎ (58 revisions)
  79. Pediatric pathology‏‎ (58 revisions)
  80. Vas deferens‏‎ (58 revisions)
  81. LP:Sandbox‏‎ (57 revisions)
  82. Head and neck cytopathology‏‎ (57 revisions)
  83. Hereditary leiomyomatosis and renal cell carcinoma syndrome‏‎ (57 revisions)
  84. Succinate dehydrogenase-deficient renal cell carcinoma‏‎ (56 revisions)
  85. Angiomyolipoma‏‎ (55 revisions)
  86. Cardiac tumours‏‎ (55 revisions)
  87. Metastases‏‎ (54 revisions)
  88. Sertoli-Leydig cell tumour‏‎ (54 revisions)
  89. An introduction to gastrointestinal pathology‏‎ (54 revisions)
  90. Spindle cell lesions‏‎ (54 revisions)
  91. Diffuse large B-cell lymphoma‏‎ (54 revisions)
  92. Endometriosis‏‎ (54 revisions)
  93. Non-small cell lung carcinoma‏‎ (53 revisions)
  94. Clinical history‏‎ (53 revisions)
  95. Trophoblast‏‎ (53 revisions)
  96. Prostate cancer grading‏‎ (52 revisions)
  97. Urinary bladder‏‎ (52 revisions)
  98. Intracranial hematomas‏‎ (52 revisions)
  99. Clear cell papillary renal cell tumour‏‎ (51 revisions)
  100. Crystals in body fluids‏‎ (51 revisions)
  101. Gastrointestinal cytopathology‏‎ (50 revisions)
  102. Intraoperative consultation‏‎ (50 revisions)
  103. Osteoarthritis‏‎ (50 revisions)
  104. Renal oncocytoma‏‎ (50 revisions)
  105. Ampulla of Vater‏‎ (49 revisions)
  106. Tuberous sclerosis‏‎ (49 revisions)
  107. Malignant mesothelioma‏‎ (49 revisions)
  108. Neuroendocrine neoplasms‏‎ (48 revisions)
  109. Pheochromocytoma‏‎ (48 revisions)
  110. L4E rule 1-3 (2014)‏‎ (47 revisions)
  111. Congenital heart disease‏‎ (47 revisions)
  112. Chromophobe renal cell carcinoma‏‎ (47 revisions)
  113. TFE3-rearranged renal cell carcinoma‏‎ (47 revisions)
  114. Granular cell tumour‏‎ (46 revisions)
  115. Hypertension‏‎ (45 revisions)
  116. Astrocytoma‏‎ (45 revisions)
  117. Pulmonary embolism‏‎ (45 revisions)
  118. Gunshot wounds‏‎ (45 revisions)
  119. Urine cytopathology‏‎ (45 revisions)
  120. Rhabdomyosarcoma‏‎ (45 revisions)
  121. Chromosomal translocations‏‎ (44 revisions)
  122. TFEB-rearranged renal cell carcinoma‏‎ (44 revisions)
  123. Breast cytopathology‏‎ (44 revisions)
  124. Desmoid-type fibromatosis‏‎ (44 revisions)
  125. Joints‏‎ (43 revisions)
  126. Familial adenomatous polyposis‏‎ (43 revisions)
  127. Craniopharyngioma‏‎ (43 revisions)
  128. Diverticular disease‏‎ (43 revisions)
  129. Sarcoidosis‏‎ (42 revisions)
  130. Basal cell carcinoma‏‎ (42 revisions)
  131. OP:Sandbox3‏‎ (42 revisions)
  132. SMARCB1-deficient renal medullary carcinoma‏‎ (42 revisions)
  133. Secretory carcinoma of the salivary gland‏‎ (42 revisions)
  134. Level 4 equivalent of 2014‏‎ (42 revisions)
  135. Renal mucinous tubular and spindle cell carcinoma‏‎ (42 revisions)
  136. Mucinous carcinoma‏‎ (42 revisions)
  137. Seminoma‏‎ (42 revisions)
  138. ELOC-mutated renal cell carcinoma‏‎ (42 revisions)
  139. Renal tumours with eosinophilic cytoplasm‏‎ (41 revisions)
  140. Leiomyoma‏‎ (41 revisions)
  141. Ependymoma‏‎ (41 revisions)
  142. Lymph node metastasis‏‎ (41 revisions)
  143. Small cell carcinoma‏‎ (41 revisions)
  144. Sjögren syndrome‏‎ (40 revisions)
  145. Signet ring cell carcinoma‏‎ (40 revisions)
  146. Nephrogenic adenoma‏‎ (40 revisions)
  147. Informatics‏‎ (40 revisions)
  148. Programmed death-ligand 1‏‎ (39 revisions)
  149. Hyperplastic polyp‏‎ (39 revisions)
  150. P16‏‎ (39 revisions)
  151. Cystic kidney diseases‏‎ (39 revisions)
  152. Giant cell arteritis‏‎ (39 revisions)
  153. Nephrotic syndrome‏‎ (38 revisions)
  154. Lymphovascular invasion‏‎ (38 revisions)
  155. Seborrheic keratosis‏‎ (38 revisions)
  156. Acquired cystic disease-associated renal cell carcinoma‏‎ (38 revisions)
  157. Leukemia‏‎ (38 revisions)
  158. Robbins and Cotran 9th Edition Questions‏‎ (38 revisions)
  159. Papillary thyroid carcinoma‏‎ (38 revisions)
  160. Cardiomyopathy‏‎ (37 revisions)
  161. Metaphyseal fibrous defect‏‎ (37 revisions)
  162. Neurofibromatosis‏‎ (37 revisions)
  163. Schwannoma‏‎ (37 revisions)
  164. Glomus tumour‏‎ (37 revisions)
  165. Total nephrectomy for tumour grossing‏‎ (36 revisions)
  166. Serous carcinoma of the ovary‏‎ (36 revisions)
  167. NUT carcinoma‏‎ (36 revisions)
  168. Pneumonia‏‎ (36 revisions)
  169. Prostate-specific antigen‏‎ (35 revisions)
  170. Lymph nodes‏‎ (35 revisions)
  171. Helicobacter gastritis‏‎ (35 revisions)
  172. Renal angiomyoadenomatous tumour‏‎ (35 revisions)
  173. Cancer staging systems‏‎ (34 revisions)
  174. Thrombotic microangiopathy‏‎ (34 revisions)
  175. Steatohepatitis‏‎ (34 revisions)
  176. GATA3‏‎ (34 revisions)
  177. Low-grade oncocytic renal tumour‏‎ (34 revisions)
  178. Renal transplant pathology‏‎ (34 revisions)
  179. Medullary thyroid carcinoma‏‎ (34 revisions)
  180. Heart transplant pathology‏‎ (34 revisions)
  181. Sessile serrated adenoma‏‎ (33 revisions)
  182. Langerhans cell histiocytosis‏‎ (33 revisions)
  183. Squamous cell carcinoma of the lung‏‎ (33 revisions)
  184. Acinic cell carcinoma‏‎ (33 revisions)
  185. Twin placentas‏‎ (33 revisions)
  186. Cervical polyps‏‎ (33 revisions)
  187. Squamous cell carcinoma of the head and neck‏‎ (33 revisions)
  188. Intraductal carcinoma of the prostate‏‎ (33 revisions)
  189. Fibromatoses‏‎ (33 revisions)
  190. Gastritis‏‎ (33 revisions)
  191. Multiple endocrine neoplasia‏‎ (33 revisions)
  192. Pulmonary alveolar proteinosis‏‎ (33 revisions)
  193. Typical carcinoid lung tumour‏‎ (33 revisions)
  194. Esophageal adenocarcinoma‏‎ (32 revisions)
  195. Intranodal palisaded myofibroblastoma‏‎ (32 revisions)
  196. Yolk sac tumour‏‎ (32 revisions)
  197. Urothelial dysplasia‏‎ (32 revisions)
  198. Principles of gross pathology‏‎ (32 revisions)
  199. Fetal autopsy‏‎ (32 revisions)
  200. Ovary‏‎ (32 revisions)
  201. Glioblastoma‏‎ (32 revisions)
  202. Granuloma‏‎ (31 revisions)
  203. Microphotography‏‎ (31 revisions)
  204. Adenocarcinoma of the urinary bladder‏‎ (31 revisions)
  205. Small cell carcinoma of the lung‏‎ (31 revisions)
  206. Sarcoma with CIC-rearrangement‏‎ (31 revisions)
  207. Lynch syndrome‏‎ (31 revisions)
  208. Critical values‏‎ (31 revisions)
  209. Chordoma‏‎ (31 revisions)
  210. Oligodendroglioma‏‎ (31 revisions)
  211. Lung cancer staging‏‎ (31 revisions)
  212. Paraganglioma‏‎ (31 revisions)
  213. Nasopharyngeal carcinoma‏‎ (31 revisions)
  214. Radiation changes‏‎ (31 revisions)
  215. Plasma cell neoplasms‏‎ (31 revisions)
  216. Colorectal cancer staging‏‎ (30 revisions)
  217. Orchiectomy grossing‏‎ (30 revisions)
  218. Pediatric kidney tumours‏‎ (30 revisions)
  219. Cytogenetics Review Questions‏‎ (30 revisions)
  220. Programmed cell death 1‏‎ (30 revisions)
  221. Urachal carcinoma‏‎ (30 revisions)
  222. Leiomyosarcoma‏‎ (30 revisions)
  223. Pleomorphic adenoma‏‎ (30 revisions)
  224. Pineal gland‏‎ (30 revisions)
  225. Pathology reports‏‎ (30 revisions)
  226. Breast grossing‏‎ (30 revisions)
  227. Cartilage‏‎ (30 revisions)
  228. Micropapillary urothelial carcinoma‏‎ (30 revisions)
  229. Cystic tumour of the atrioventricular nodal region‏‎ (29 revisions)
  230. Lung carcinoma with ALK rearrangement‏‎ (29 revisions)
  231. Hemophagocytic syndrome‏‎ (29 revisions)
  232. Teratoma‏‎ (29 revisions)
  233. Tubulocystic carcinoma of the kidney‏‎ (29 revisions)
  234. ALK translocation renal cell carcinoma‏‎ (29 revisions)
  235. Multilocular cystic renal neoplasm of low malignant potential‏‎ (29 revisions)
  236. Adenoid cystic carcinoma‏‎ (29 revisions)
  237. Mucoepidermoid carcinoma‏‎ (29 revisions)
  238. TRK fusions‏‎ (28 revisions)
  239. Wilms tumour‏‎ (28 revisions)
  240. Peritoneum‏‎ (28 revisions)
  241. Urothelial carcinoma in situ‏‎ (28 revisions)
  242. Squamous cell carcinoma of the skin‏‎ (28 revisions)
  243. Embryonal carcinoma‏‎ (28 revisions)
  244. Quiz:L4E uropathology (2014)‏‎ (28 revisions)
  245. Warthin tumour‏‎ (28 revisions)
  246. Acute appendicitis‏‎ (28 revisions)
  247. CSF cytopathology‏‎ (28 revisions)
  248. Waffle diagnosis‏‎ (28 revisions)
  249. Libre Pathology news‏‎ (28 revisions)
  250. Vagina‏‎ (28 revisions)
  251. Burkitt lymphoma‏‎ (27 revisions)
  252. Zoon vulvitis‏‎ (27 revisions)
  253. Anastomosing hemangioma of the kidney‏‎ (27 revisions)
  254. Neuroanatomy‏‎ (27 revisions)
  255. End-stage kidney‏‎ (27 revisions)
  256. Polymorphous adenocarcinoma‏‎ (27 revisions)
  257. Pathology requisitions‏‎ (27 revisions)
  258. Molecular pathology tests‏‎ (27 revisions)
  259. Cystoprostatectomy grossing‏‎ (27 revisions)
  260. Pneumocytoma‏‎ (27 revisions)
  261. Cytogenetics‏‎ (26 revisions)
  262. Pseudomembranous colitis‏‎ (26 revisions)
  263. Starvation‏‎ (26 revisions)
  264. Adrenocortical carcinoma‏‎ (26 revisions)
  265. Granulomatous prostatitis‏‎ (26 revisions)
  266. Squamous cell carcinoma of the penis‏‎ (26 revisions)
  267. KRAS mutation‏‎ (26 revisions)
  268. Leydig cell tumour‏‎ (26 revisions)
  269. Neuroendocrine tumour of the pancreas‏‎ (26 revisions)
  270. Angiosarcoma‏‎ (26 revisions)
  271. Sudden natural death‏‎ (26 revisions)
  272. Mucinous cystadenoma of the ovary‏‎ (26 revisions)
  273. Ileocecal valve‏‎ (26 revisions)
  274. Classification of urothelial carcinoma by immunohistochemistry‏‎ (25 revisions)
  275. Cancer‏‎ (25 revisions)
  276. Complex endometrial hyperplasia‏‎ (25 revisions)
  277. Case:Blank‏‎ (25 revisions)
  278. Mixed germ cell tumour‏‎ (25 revisions)
  279. Serous cystadenoma of the ovary‏‎ (25 revisions)
  280. Foreign material‏‎ (25 revisions)
  281. Atypical teratoid/rhabdoid tumour‏‎ (25 revisions)
  282. Parathyroid hyperplasia‏‎ (25 revisions)
  283. Autosomal dominant polycystic kidney disease‏‎ (25 revisions)
  284. Prostate cancer staging‏‎ (25 revisions)
  285. Carcinoma ex pleomorphic adenoma‏‎ (25 revisions)
  286. Medulloblastoma‏‎ (25 revisions)
  287. Pleural invasion‏‎ (25 revisions)
  288. Fecal material‏‎ (25 revisions)
  289. Tuberous sclerosis-associated renal cell carcinoma‏‎ (25 revisions)
  290. Brenner tumour‏‎ (25 revisions)
  291. Goblet cell adenocarcinoma‏‎ (25 revisions)
  292. Psammoma bodies‏‎ (24 revisions)
  293. L4E rule 7-8 (2014)‏‎ (24 revisions)
  294. Crohn's disease‏‎ (24 revisions)
  295. Large epithelioid tumours‏‎ (24 revisions)
  296. Pathology for medical students‏‎ (24 revisions)
  297. Germ cell neoplasia in situ‏‎ (24 revisions)
  298. Parathyroid adenoma‏‎ (24 revisions)
  299. Von Hippel-Lindau disease‏‎ (24 revisions)
  300. Adenocarcinoma‏‎ (24 revisions)
  301. Panniculitis‏‎ (24 revisions)
  302. Clear cell carcinoma‏‎ (24 revisions)
  303. Eccrine spiradenoma‏‎ (24 revisions)
  304. Prostatic stromal tumour of uncertain malignant potential‏‎ (24 revisions)
  305. Renal hybrid oncocytic/chromophobe tumour‏‎ (24 revisions)
  306. Necrosis‏‎ (24 revisions)
  307. Biphenotypic sinonasal sarcoma‏‎ (24 revisions)
  308. Hemangioma‏‎ (24 revisions)
  309. Rosai-Dorfman disease‏‎ (24 revisions)
  310. Cystic nephroma, adult type‏‎ (24 revisions)
  311. Barrett's esophagus‏‎ (23 revisions)
  312. Choriocarcinoma‏‎ (23 revisions)
  313. Chondromyxoid fibroma‏‎ (23 revisions)
  314. Lymphoepithelioma-like carcinoma of the urinary bladder‏‎ (23 revisions)
  315. Desquamative interstitial pneumonia‏‎ (23 revisions)
  316. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features‏‎ (23 revisions)
  317. Stomach carcinoma‏‎ (23 revisions)
  318. Epithelioid hemangioendothelioma‏‎ (23 revisions)
  319. Endometrioid endometrial carcinoma‏‎ (23 revisions)
  320. In-transit metastasis‏‎ (23 revisions)
  321. Apocrine carcinoma of the breast‏‎ (23 revisions)
  322. Sarcina‏‎ (23 revisions)
  323. Squamous cell carcinoma of the urinary bladder‏‎ (23 revisions)
  324. Anatomical pathology laboratory processes‏‎ (23 revisions)
  325. Course:Introduction to Neuropathology‏‎ (23 revisions)
  326. Squamous intraepithelial lesion of the uterine cervix‏‎ (23 revisions)
  327. Syphilis‏‎ (23 revisions)
  328. Nodular hyperplasia of the prostate gland‏‎ (23 revisions)
  329. Pulmonary hypertension‏‎ (23 revisions)
  330. Electron microscopy‏‎ (22 revisions)
  331. Leydig cell hyperplasia‏‎ (22 revisions)
  332. Metanephric adenoma‏‎ (22 revisions)
  333. Brain metastasis‏‎ (22 revisions)
  334. Vascular malformations‏‎ (22 revisions)
  335. Diagnosis‏‎ (22 revisions)
  336. Small bowel pseudomelanosis‏‎ (22 revisions)
  337. Pulmonary blastoma‏‎ (22 revisions)
  338. Renal oncocytosis‏‎ (22 revisions)
  339. Hepatocellular carcinoma‏‎ (22 revisions)
  340. Follicular dendritic cell sarcoma‏‎ (22 revisions)
  341. Malakoplakia‏‎ (22 revisions)
  342. Smoking‏‎ (22 revisions)
  343. Atypical adenomatous hyperplasia of the lung‏‎ (22 revisions)
  344. Adamantinoma‏‎ (22 revisions)
  345. Proliferative phase endometrium‏‎ (22 revisions)
  346. Cribriform adenocarcinoma of the minor salivary gland‏‎ (22 revisions)
  347. Liver metastasis‏‎ (22 revisions)
  348. Plasma cell‏‎ (22 revisions)
  349. Fibroadenoma‏‎ (22 revisions)
  350. Pilocytic astrocytoma‏‎ (22 revisions)
  351. Histology artifacts‏‎ (22 revisions)
  352. Pseudomelanosis coli‏‎ (22 revisions)
  353. Fundic gland polyp‏‎ (21 revisions)
  354. Red blood cell‏‎ (21 revisions)
  355. Autoimmune hepatitis‏‎ (21 revisions)
  356. Pressure ulcer‏‎ (21 revisions)
  357. IgG4-related systemic diseases‏‎ (21 revisions)
  358. Lichen sclerosus‏‎ (21 revisions)
  359. Histiocytoses‏‎ (21 revisions)
  360. SMARCB1‏‎ (21 revisions)
  361. Thyroid imaging reporting and data system‏‎ (21 revisions)
  362. Light microscopy‏‎ (21 revisions)
  363. Systemic lupus erythematosus‏‎ (21 revisions)
  364. Lymphocytic colitis‏‎ (21 revisions)
  365. Human immunodeficiency virus‏‎ (21 revisions)
  366. Sinonasal undifferentiated carcinoma‏‎ (21 revisions)
  367. Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis‏‎ (21 revisions)
  368. Intestinal metaplasia of the stomach‏‎ (21 revisions)
  369. Loop electrosurgical excision procedure‏‎ (21 revisions)
  370. Immune thrombocytopenic purpura‏‎ (21 revisions)
  371. Reactive gastropathy‏‎ (21 revisions)
  372. Lymphangioleiomyomatosis‏‎ (21 revisions)
  373. Abusive head trauma‏‎ (21 revisions)
  374. Prostate chips grossing‏‎ (21 revisions)
  375. Adenocarcinoma of the rete testis‏‎ (21 revisions)
  376. Salivary duct carcinoma‏‎ (21 revisions)
  377. Eosinophilic esophagitis‏‎ (21 revisions)
  378. Case 1‏‎ (21 revisions)
  379. Parathyroid carcinoma‏‎ (21 revisions)
  380. Gout‏‎ (21 revisions)
  381. Diagnostic size cutoffs‏‎ (21 revisions)
  382. Papillary cystadenoma of the epididymis‏‎ (21 revisions)
  383. Phosphaturic mesenchymal tumour, mixed connective tissue type‏‎ (20 revisions)
  384. Nasal polyps‏‎ (20 revisions)
  385. Acute cholecystitis‏‎ (20 revisions)
  386. Follicular lymphoma‏‎ (20 revisions)
  387. Invasive ductal carcinoma of the breast‏‎ (20 revisions)
  388. Hepatocyte nuclear factor-1beta‏‎ (20 revisions)
  389. Radical cystectomy grossing‏‎ (20 revisions)
  390. Ganglioglioma‏‎ (20 revisions)
  391. Hepatitis B‏‎ (20 revisions)
  392. Giant cells‏‎ (20 revisions)
  393. Juxtaglomerular cell tumour‏‎ (20 revisions)
  394. High-grade prostatic intraepithelial neoplasia‏‎ (20 revisions)
  395. Avascular necrosis of the femoral head‏‎ (20 revisions)
  396. Intestinal metaplasia of the gallbladder‏‎ (20 revisions)
  397. Reactive changes‏‎ (20 revisions)
  398. Lymph node grossing‏‎ (20 revisions)
  399. Low-grade squamous intraepithelial lesion‏‎ (20 revisions)
  400. Kidney cancer staging‏‎ (20 revisions)
  401. Case 2‏‎ (20 revisions)
  402. Cholangiocarcinoma‏‎ (20 revisions)
  403. Fibrous dysplasia‏‎ (20 revisions)
  404. High-grade papillary urothelial carcinoma‏‎ (20 revisions)
  405. Hereditary breast cancer‏‎ (20 revisions)
  406. Porocarcinoma‏‎ (20 revisions)
  407. Chondroblastoma‏‎ (20 revisions)
  408. Usual interstitial pneumonia‏‎ (20 revisions)
  409. Gaucher disease‏‎ (19 revisions)
  410. Miscellaneous ovarian tumours‏‎ (19 revisions)
  411. Paired box gene 8‏‎ (19 revisions)
  412. Epidermal necrosis‏‎ (19 revisions)
  413. Tissue fixation‏‎ (19 revisions)
  414. Keratinising squamous metaplasia of the urinary bladder‏‎ (19 revisions)
  415. Case 47‏‎ (19 revisions)
  416. Carbonic anhydrase 9‏‎ (19 revisions)
  417. Colitis cystica profunda‏‎ (19 revisions)
  418. Pityriasis rubra pilaris‏‎ (19 revisions)
  419. CoPath‏‎ (19 revisions)
  420. MUTYH polyposis syndrome‏‎ (19 revisions)
  421. Invasive ductal carcinoma of the pancreas‏‎ (19 revisions)
  422. Foregut primary carcinomas‏‎ (19 revisions)
  423. Small vessel leukocytoclastic vasculitis‏‎ (19 revisions)
  424. Colorectal xanthomatous polyp‏‎ (19 revisions)
  425. Xanthogranulomatous pyelonephritis‏‎ (19 revisions)
  426. Bizarre parosteal osteochondromatous proliferation‏‎ (19 revisions)
  427. Mucinous tumours of the appendix‏‎ (19 revisions)
  428. Renal cell carcinoma with sarcomatoid differentiation‏‎ (19 revisions)
  429. Traditional serrated adenoma‏‎ (19 revisions)
  430. Omentum‏‎ (19 revisions)
  431. Ischemic colitis‏‎ (19 revisions)
  432. Schmorl's node‏‎ (19 revisions)
  433. Tumour budding‏‎ (19 revisions)
  434. Xanthogranulomatous cholecystitis‏‎ (19 revisions)
  435. Pulmonary hamartoma‏‎ (18 revisions)
  436. Kimura disease‏‎ (18 revisions)
  437. Intraductal papilloma of the breast‏‎ (18 revisions)
  438. Mesenchymal chondrosarcoma‏‎ (18 revisions)
  439. C-cell hyperplasia‏‎ (18 revisions)
  440. Spine‏‎ (18 revisions)
  441. Inflammatory myofibroblastic tumour‏‎ (18 revisions)
  442. Neurofibroma‏‎ (18 revisions)
  443. Eosinophilic vacuolated tumour‏‎ (18 revisions)
  444. BRAF V600E mutation‏‎ (18 revisions)
  445. Quiz: Lung lesions 1‏‎ (18 revisions)
  446. Malignant peripheral nerve sheath tumour‏‎ (18 revisions)
  447. Carney complex‏‎ (18 revisions)
  448. Endometrium with squamous morules‏‎ (18 revisions)
  449. Testicular metastasis‏‎ (18 revisions)
  450. Ganglion cyst‏‎ (18 revisions)
  451. Granulation tissue‏‎ (18 revisions)
  452. OP:Sandbox2‏‎ (18 revisions)
  453. Sex cord tumour with annular tubules‏‎ (18 revisions)
  454. Walthard cell rest‏‎ (18 revisions)
  455. Keloid‏‎ (18 revisions)
  456. Kidney‏‎ (18 revisions)
  457. CNS cytopathology‏‎ (18 revisions)
  458. Eyelid‏‎ (18 revisions)
  459. Cowden syndrome‏‎ (18 revisions)
  460. Hyaline globules‏‎ (18 revisions)
  461. Amebiasis‏‎ (18 revisions)
  462. Clear cell tumours‏‎ (18 revisions)
  463. Spermatocytic tumour‏‎ (18 revisions)
  464. Lipoma‏‎ (18 revisions)
  465. Diabetes mellitus‏‎ (18 revisions)
  466. Localized cystic disease of the kidney‏‎ (18 revisions)
  467. Drug toxicity‏‎ (18 revisions)
  468. Testicular scar‏‎ (18 revisions)
  469. Trisomy 13‏‎ (18 revisions)
  470. Autoimmune metaplastic atrophic gastritis‏‎ (18 revisions)
  471. Testicular adrenal rest tumour‏‎ (18 revisions)
  472. Liposarcoma‏‎ (18 revisions)
  473. Mucinous breast carcinoma‏‎ (18 revisions)
  474. Human papillomavirus-associated head and neck squamous cell carcinoma‏‎ (18 revisions)
  475. Pulmonary carcinoid tumourlet‏‎ (18 revisions)
  476. Penile intraepithelial neoplasia‏‎ (18 revisions)
  477. Actinic keratosis‏‎ (18 revisions)
  478. Case:Notes‏‎ (18 revisions)
  479. Ethanol abuse‏‎ (17 revisions)
  480. Penectomy grossing‏‎ (17 revisions)
  481. Sinus histiocytosis‏‎ (17 revisions)
  482. Myelodysplastic syndromes‏‎ (17 revisions)
  483. Desmoplasia‏‎ (17 revisions)
  484. Oncocytoma of the salivary gland‏‎ (17 revisions)
  485. SMARCA4-deficient non-small cell carcinoma of the lung‏‎ (17 revisions)
  486. Adenosquamous carcinoma of the lung‏‎ (17 revisions)
  487. Granuloma annulare‏‎ (17 revisions)
  488. Eosinophilic, solid and cystic renal cell carcinoma‏‎ (17 revisions)
  489. Emphysema‏‎ (17 revisions)
  490. Unclassified renal cell carcinoma‏‎ (17 revisions)
  491. Microsatellite instability in colorectal cancer‏‎ (17 revisions)
  492. Muscularis propria invasion in the urinary bladder‏‎ (17 revisions)
  493. Testicular torsion‏‎ (17 revisions)
  494. Pigmented spindle cell nevus‏‎ (17 revisions)
  495. Physical examination‏‎ (17 revisions)
  496. Graft-versus-host disease‏‎ (17 revisions)
  497. Enteropathy-associated T-cell lymphoma‏‎ (17 revisions)
  498. Epidermal inclusion cyst‏‎ (17 revisions)
  499. Common variable immunodeficiency‏‎ (17 revisions)
  500. Paneth cell‏‎ (17 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)